[HTML][HTML] Radiotherapy targeting cancer stem cells “awakens” them to induce tumour relapse and metastasis in oral cancer
Y Liu, M Yang, J Luo, H Zhou - International journal of oral science, 2020 - nature.com
Radiotherapy is one of the most common treatments for oral cancer. However, in the clinic,
recurrence and metastasis of oral cancer occur after radiotherapy, and the underlying …
recurrence and metastasis of oral cancer occur after radiotherapy, and the underlying …
[HTML][HTML] The economic burden of head and neck cancer: a systematic literature review
E Wissinger, I Griebsch, J Lungershausen, T Foster… - …, 2014 - Springer
Background This systematic literature review aimed to evaluate and summarize the existing
evidence on resource use and costs associated with the diagnosis and treatment of head …
evidence on resource use and costs associated with the diagnosis and treatment of head …
Safety and efficacy of nivolumab monotherapy in recurrent or metastatic cervical, vaginal, or vulvar carcinoma: results from the phase I/II CheckMate 358 trial
PURPOSE Nivolumab was assessed in patients with virus-associated tumors in the phase
I/II CheckMate 358 trial (ClinicalTrials. gov identifier: NCT02488759). We report on patients …
I/II CheckMate 358 trial (ClinicalTrials. gov identifier: NCT02488759). We report on patients …
[HTML][HTML] Bacterial alterations in salivary microbiota and their association in oral cancer
WH Lee, HM Chen, SF Yang, C Liang, CY Peng… - Scientific reports, 2017 - nature.com
Oral squamous cell carcinoma (OSCC) is the most common malignant neoplasm of the oral
cavity and the fourth leading malignancy and cause of cancer-related death in the male …
cavity and the fourth leading malignancy and cause of cancer-related death in the male …
[HTML][HTML] A randomized, phase II study of afatinib versus cetuximab in metastatic or recurrent squamous cell carcinoma of the head and neck
TY Seiwert, J Fayette, D Cupissol, JM Del Campo… - Annals of oncology, 2014 - Elsevier
Background Afatinib is an oral, irreversible ErbB family blocker that has shown activity in
epidermal growth factor receptor (EGFR)-mutated lung cancer. We hypothesized that the …
epidermal growth factor receptor (EGFR)-mutated lung cancer. We hypothesized that the …
Plectin promotes migration and invasion of cancer cells and is a novel prognostic marker for head and neck squamous cell carcinoma
Head and neck squamous cell carcinoma (HNSCC) is usually found at a late stage and
distant metastasis occurs at high frequency; therefore, novel prognostic markers are needed …
distant metastasis occurs at high frequency; therefore, novel prognostic markers are needed …
Local drug delivery for oral mucosal diseases: challenges and opportunities
V Sankar, V Hearnden, K Hull, DV Juras… - Oral …, 2011 - Wiley Online Library
Oral Diseases (2011) 17 (Suppl. 1), 73–84 There are few topical formulations used for oral
medicine applications most of which have been developed for the management of …
medicine applications most of which have been developed for the management of …
Nimotuzumab plus radiotherapy for unresectable squamous-cell carcinoma of the head and neck
MO Rodríguez, TC Rivero… - Cancer biology & …, 2010 - Taylor & Francis
The prognosis of patients with advanced head and neck cancer remain dismal. For this
tumor type, elevated levels of EGFR are associated with a shorter disease free survival and …
tumor type, elevated levels of EGFR are associated with a shorter disease free survival and …
Oral complications of targeted cancer therapies: a narrative literature review
AL Watters, JB Epstein, M Agulnik - Oral oncology, 2011 - Elsevier
The aim of the present study was to investigate the available literature regarding the oral
side effects or adverse events associated with targeted cancer therapy. Common oral …
side effects or adverse events associated with targeted cancer therapy. Common oral …
Epidermal growth factor receptor expression and gene copy number in the risk of oral cancer
M Taoudi Benchekroun, P Saintigny, SM Thomas… - Cancer prevention …, 2010 - AACR
Leukoplakia is the most common premalignant lesion of the oral cavity. Epidermal growth
factor receptor (EGFR) abnormalities are associated with oral tumorigenesis and …
factor receptor (EGFR) abnormalities are associated with oral tumorigenesis and …